Clinical Trials
From MaRDI portal
Publication:5693362
DOI10.1002/0471740136zbMath1081.62102OpenAlexW4231404455MaRDI QIDQ5693362
Publication date: 26 September 2005
Published in: Wiley Series in Probability and Statistics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1002/0471740136
Applications of statistics to biology and medical sciences; meta analysis (62P10) Optimal statistical designs (62K05) Introductory exposition (textbooks, tutorial papers, etc.) pertaining to statistics (62-01) Research exposition (monographs, survey articles) pertaining to statistics (62-02) Medical applications (general) (92C50)
Related Items
A New Semiparametric Estimation Method for Accelerated Hazard Model, Designs for Single- or Multiple-Agent Phase I Trials, Confidence interval for the difference between two median survival times with semiparametric transformation models, GROUP SEQUENTIAL TESTS WITH OUTCOME-DEPENDENT TREATMENT ASSIGNMENT, Choice as an alternative to control in observational studies. (With comments and a rejoinder)., Global testing under sparse alternatives: ANOVA, multiple comparisons and the higher criticism, Sample Size Re-Estimation Based on Two-Stage Analysis of Variance: Interim Analysis of Clinical Trials, Semiparametric Estimation of Proportional Mean Residual Life Model in Presence of Censoring, Stratified Analysis in Randomized Trials with Noncompliance, Semiparametric Bayesian Survival Analysis using Models with Log‐linear Median, Interval estimation of odds ratio in a stratified randomized clinical trial with noncompliance, Is the FDA too conservative or too aggressive?: a Bayesian decision analysis of clinical trial design, Building an identifiable latent class model with covariate effects on underlying and measured variables, Proportional hazards models with random effects to examine centre effects in multicentre cancer clinical trials, Chain Graph Models and their Causal Interpretations, An Empirical Bayes Method for Multivariate Meta-analysis with an Application in Clinical Trials, Statistical analysis of survival and reliability data with multiple crossings of survival functions, A class of mean residual life regression models with censored survival data, Accelerated Hazards Regression Model and Its Adequacy for Censored Survival Data, Simulation of clinical trials: a review with emphasis on the design issues, Randomized group up and down experiments, Estimating Incidence Rate on Current Status Data with Application to a Phase IV Cancer Trial
